VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of participation in this study is to answer whether teriparatide is
superior to risedronate in reducing the occurrence of new vertebral fractures during 24
months of therapy.